By ipomarket.in Editorial Team · Last reviewed: 2026-11-18
Disclaimer: This article is for informational purposes only and does not constitute investment advice. IPO investments are subject to market risks. Please read the offer document carefully and consult a SEBI-registered investment advisor before investing.
The Securities and Exchange Board of India (SEBI) has set up a sub-group under its Primary Market Advisory Committee (PMAC) to review the rules that govern IPOs and other fundraising routes. The move signals an intent to re-examine long-standing norms, but it is important to be clear up front: no rule has been changed, and no deadline has been set for the panel's report.
For retail investors, this is a process story rather than an outcome story. It tells you what SEBI is thinking about, not what the rules will become. Below is a plain breakdown of who is on the panel, what it is reviewing, and why it matters to anyone who follows the primary market.
Who is leading the review
The sub-group is headed by Ashishkumar Chauhan, MD and CEO of the National Stock Exchange (NSE). According to reports, the panel has 10 members in total, with nine members drawn from stock exchanges, professional bodies, investment banking and legal firms alongside Chauhan.
The sub-group may also co-opt additional members or invite subject matter experts and other stakeholders for its deliberations. Whatever it concludes will not become policy on its own. Its recommendations will be placed before PMAC for consideration, and PMAC in turn advises SEBI. In other words, there are several steps between this panel's work and any actual rule change.
What the panel is reviewing
The sub-group will look at several chapters of SEBI's ICDR Regulations. ICDR stands for Issue of Capital and Disclosure Requirements, the rulebook that sets out how companies raise money from the public market and what they must disclose when they do.
The scope covers:
- Eligibility conditions for IPOs — the thresholds a company must meet before it can list.
- Follow-on public offers (FPOs) — fresh share sales by companies that are already listed. (For how an FPO differs from an IPO, see our explainer on the IPO vs FPO difference.)
- Preferential issues — share allotments to a select set of investors.
- Qualified institutional placements (QIPs) — fundraising from institutional buyers.
Alongside these, the panel will review pricing requirements and the price discovery framework, which is the process by which an IPO's price band and final price get set. It will also look at promoter capital lock-in terms and due diligence obligations, as well as related circulars and orders.
The lock-in point is worth flagging for retail investors, because promoter and anchor lock-in periods affect how much stock can hit the market after listing. Our guide on the IPO lock-in period for promoters and anchor investors explains why those timelines matter.
Why SEBI is doing this
SEBI has framed the exercise around ease of access. The stated aim of the sub-group is to simplify rules, reduce the compliance burden, and make it easier to access capital markets.
The broader review, in SEBI's own words, is meant to identify opportunities to facilitate ease of access to the capital market for eligible issuers, simplify and rationalise regulatory requirements, eliminate duplicative disclosures and procedures, and improve regulatory clarity and consistency. Crucially, SEBI says this must happen while maintaining adequate disclosures, investor protection and market integrity.
That last clause matters. Cutting compliance for companies and protecting investors can pull in opposite directions, so the balance the panel strikes will be the thing to watch when and if recommendations emerge.
What this means for retail investors right now
Nothing changes today. No rule has been changed and no date has been given for the panel's report, so there is no new filing requirement, no new eligibility threshold, and no new pricing mechanism to factor into how you read an IPO.
If you are evaluating an upcoming issue, the existing framework still applies. The DRHP remains your primary source document, and understanding how to read it is more useful than speculating on future rules. Our walkthrough on what a DRHP is and how to read it covers the parts that actually affect your decision.
Where this review becomes relevant is over the medium term. Any change to eligibility conditions, pricing, or lock-in rules could reshape which companies can list and on what terms. That is a story to track, not to trade on. For now, treat the panel's formation as a signal of direction rather than a settled change.
FAQ
Who heads the new SEBI sub-group on IPO rules?
The sub-group is headed by Ashishkumar Chauhan, MD and CEO of the National Stock Exchange (NSE). It sits under SEBI's Primary Market Advisory Committee (PMAC).
How many members are on the panel?
Reports indicate the panel has 10 members in total, with nine drawn from stock exchanges, professional bodies, investment banking and legal firms, alongside Chauhan. The sub-group may also co-opt additional members or invite experts for its deliberations.
What rules is the panel reviewing?
It is reviewing several chapters of the ICDR Regulations, covering eligibility conditions for IPOs, FPOs, preferential issues and QIPs, pricing requirements, the price discovery framework, promoter capital lock-in terms, due diligence obligations, and related circulars and orders.
Have any IPO rules changed because of this?
No. No rule has been changed and no date has been given for the panel's report. The sub-group's recommendations will first be placed before PMAC for consideration before anything can become policy.
Will this make it easier for companies to list?
That is the stated intent. SEBI says the review aims to simplify rules, reduce the compliance burden and make it easier to access capital markets, while maintaining adequate disclosures, investor protection and market integrity. But the actual outcome depends on the final recommendations, which are not yet available.
Last reviewed: 2026-11-18. This is a developing regulatory story; figures and scope reflect reports available as of this date.